ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, announced today that it will present at the following three investor conferences in February:
• 18th Annual BIO CEO & Investor Conference in New York City on Tuesday, February 9 at 2:00 p.m. ET
• Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference in New York City on Wednesday, February 10, 2016 at 8:30 a.m. ET
